Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Here We Go Again: Novartis Fined for Off-Label Marketing
Seeking Alpha
Sunday, October 3, 2010 - 12:22pm
tags:
Novartis, off label
Glaxo Meets Big Disappointment in Failed Herpes Vaccine
Seeking Alpha
Sunday, October 3, 2010 - 12:22pm
tags:
GSK, herpes simplex vaccine
Teva launches prostate cancer Phase III study
Globes, Israel
Sunday, October 3, 2010 - 12:18pm
tags:
Teva Pharmaceuticals, OncoGenex, prostate cancer
Court Ruling Increases Pressure on Sanofi to Buy Genzyme
Seeking Alpha
Sunday, October 3, 2010 - 12:17pm
tags:
Sanofi, Genzyme, M&A
Amyris Completes IPO With Impressive Partnerships Pipeline: Biotech's Latest Deals
Seeking Alpha
Sunday, October 3, 2010 - 12:16pm
tags:
Amyris, antimalarial
Baxter Receives Approval For PREFLUCEL Seasonal Influenza Vaccine In Austria
Medical News Today
Sunday, October 3, 2010 - 12:14pm
tags:
Baxter International, Preflucel, flu vaccine
Losers at NYSE Healthcare Sector (BSX, THC, ELN, HMA, KG)
Penny Stock Live
Sunday, October 3, 2010 - 12:10pm
tags:
Boston Scientific, Elan, King
Immunogen's T-DM1 Gets Presidential Treatment
Seeking Alpha
Sunday, October 3, 2010 - 11:48am
tags:
Immunogen, T-DM1, breast cancer
FDA Warns Gilead About Manufacturing Problems: How Serious Is It?
Seeking Alpha
Sunday, October 3, 2010 - 11:46am
tags:
Gilead Sciences
Mylan Launches Generic Version of Wellbutrin XL® Tablets
Bradenton Herald, FL
Saturday, October 2, 2010 - 11:34am
tags:
Mylan, Wellbutrin XL, GSK
J&J Warns of Sales-Force Layoffs
WSJ
Saturday, October 2, 2010 - 11:27am
tags:
JNJ
AstraZeneca to Start Brilinta Heart Attack Study
Bloomberg
Saturday, October 2, 2010 - 11:24am
tags:
AstraZeneca, Brilinta, Plavix, Sanofi, heart attacks
Bionovo to Raise $3 Million Through Registered Direct Offering
Yahoo/PR NewsWire
Saturday, October 2, 2010 - 11:22am
tags:
Bionovo, investors
Array BioPharma Announces Positive Results for HER2 Inhibitor, ARRY-380, in Breast Cancer Patients
Yahoo/BusinessWire
Saturday, October 2, 2010 - 11:20am
tags:
Array Biopharma, breast cancer, ARRY-380, HER2 Inhibitor
Biogen Cut to Neutral
Yahoo/Zacks
Saturday, October 2, 2010 - 11:18am
tags:
Biogen Idec, investors
Novartis Whistleblower Speaks: ‘We Wasted Money’
Pharmalot
Friday, October 1, 2010 - 12:43pm
tags:
Novartis, whistleblowers, off-label
Sunesis plans to raise $15.5M in public offering
Bizjournals.com
Friday, October 1, 2010 - 12:38pm
tags:
Sunesis, stock offering
Drug Sales Reps’ OT Demand Will Sort Micromanagers From Soft Touches
BNET Pharma
Friday, October 1, 2010 - 12:23pm
tags:
overtime lawsuits, drug reps
Merck returns drug rights to AVEO
Fierce Biotech
Friday, October 1, 2010 - 12:21pm
tags:
Aveo Pharmaceutical, Merck, antibodies
FDA delays ruling on Teva version of Amgen drug
Yahoo/AP
Friday, October 1, 2010 - 12:16pm
tags:
Teva Pharmaceuticals, FDA, neutropenia, generics, Amgen, Neupogen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.